Cargando…

One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database

IMPORTANCE: Many individuals experience ongoing symptoms following the onset of COVID-19, characterized as postacute sequelae of SARS-CoV-2 or post–COVID-19 condition (PCC). Less is known about the long-term outcomes for these individuals. OBJECTIVE: To quantify 1-year outcomes among individuals mee...

Descripción completa

Detalles Bibliográficos
Autores principales:	DeVries, Andrea, Shambhu, Sonali, Sloop, Sue, Overhage, J. Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984976/ https://www.ncbi.nlm.nih.gov/pubmed/36867420 http://dx.doi.org/10.1001/jamahealthforum.2023.0010

Ejemplares similares

Identification and Comparison of Patient Characteristics for Those Hospitalized with COVID-19 versus Influenza Using Machine Learning in a Commercially Insured US Population
por: Chen, Xiaoxue, et al.
Publicado: (2021)

Trends in Infertility Care Among Commercially Insured US Women During the COVID-19 Pandemic
por: Zhou, Beth, et al.
Publicado: (2021)

Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
por: Whaley, Christopher M., et al.
Publicado: (2020)

COVID-19 and the US health insurance conundrum
por: The Lancet Oncology
Publicado: (2020)

Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic
por: Li, Kun, et al.
Publicado: (2022)

Prevalence of Mental Health Diagnoses in Commercially Insured Children and Adolescents in the US Before and During the COVID-19 Pandemic
por: Straub, Loreen, et al.
Publicado: (2023)

U.S. Unemployment insurance through the Covid-19 crisis
por: Spadafora, Francesco
Publicado: (2023)

Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)

The association between COVID-19 infection and incident atrial fibrillation: results from a retrospective cohort study using a large US commercial insurance database
por: Berman, Adam, et al.
Publicado: (2023)

Cross-Sectional Trends in Potentially Low-Value Services for Commercially Insured Patients With Chronic Low Back Pain
por: Pham, Timothy, et al.
Publicado: (2022)

Comparing cardiovascular risk of patients with rheumatoid arthritis within the Social Security Disability Insurance with those commercially insured
por: Navarro-Millán, Iris, et al.
Publicado: (2022)

Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic
por: Cantor, Jonathan, et al.
Publicado: (2021)

Mental Health Service Utilization Rates Among Commercially Insured Adults in the US During the First Year of the COVID-19 Pandemic
por: McBain, Ryan K., et al.
Publicado: (2023)

An analysis of fatal adverse conditions in temporal association of COVID-19 vaccination to boost the safety of vaccination for COVID-19
por: Muslim, Shahnawaz, et al.
Publicado: (2023)

Temporal trend in the use of hysteroscopic vs laparoscopic sterilization and the characteristics of commercially insured and Medicaid-insured females in the US who have had the procedures
por: Carney, Patricia I, et al.
Publicado: (2016)

Together we are stronger: COVID-19 for those of us with pre-existing conditions
por: Pavanello, Stefano
Publicado: (2020)

Commercial COVID-19 PCR Test Price in US Hospitals
por: Jiang, John Xuefeng, et al.
Publicado: (2023)

Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients
por: Gunturu, Krishna S., et al.
Publicado: (2022)

Changes in Postpartum Insurance Coverage in the US During the COVID-19 Pandemic
por: Eliason, Erica L., et al.
Publicado: (2022)

Trends in US Health Insurance Coverage During the COVID-19 Pandemic
por: Bundorf, M. Kate, et al.
Publicado: (2021)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Remdesivir vs tocilizumab in COVID-19: adverse event profiles
Publicado: (2021)

Risk of Operative and Nonoperative Interventions Up to 4 Years After Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in a Nationwide US Commercial Insurance Claims Database
por: Lewis, Kristina H., et al.
Publicado: (2019)

The Impact of COVID-19: Perspectives of Recreational Therapists Working with Older Adults
por: Kemeny, Betsy, et al.
Publicado: (2021)

Use of and Comorbidities Associated With Diagnostic Codes for COVID-19 in US Health Insurance Claims
por: Yang, Kai-Cheng, et al.
Publicado: (2021)

Risk of Coronavirus Disease 2019 (COVID-19) among those up-to-date and not up-to-date on COVID-19 vaccination by US CDC criteria
por: Shrestha, Nabin K., et al.
Publicado: (2023)

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
por: Solem, Caitlyn T., et al.
Publicado: (2014)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population
por: Funch, Donnie, et al.
Publicado: (2019)

Consistency and Adequacy of Public and Commercial Health Insurance for US Children, 2016 to 2021
por: Daw, Jamie R., et al.
Publicado: (2023)

Outcomes of In-Person and Telehealth Ambulatory Encounters During COVID-19 Within a Large Commercially Insured Cohort
por: Hatef, Elham, et al.
Publicado: (2022)

Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database
por: Cho, Soo Ick, et al.
Publicado: (2021)

The Impact of COVID-19 on the Insurance Industry
por: Babuna, Pius, et al.
Publicado: (2020)

Unemployment insurance claims and COVID-19
por: Sjoquist, David, et al.
Publicado: (2021)

Adverse drug event risk assessment by the virtual addition of COVID‐19 repurposed drugs to Medicare and commercially insured patients’ drug regimens: A drug safety simulation study
por: Smith, Matt K., et al.
Publicado: (2021)

Systemic overuse of health care in a commercially insured US population, 2010–2015
por: Oakes, Allison H., et al.
Publicado: (2019)

No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients
por: Pyenson, Bruce S., et al.
Publicado: (2019)

Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016
por: Pauly, Nathan J., et al.
Publicado: (2020)

Costs of Severe Maternal Morbidity in U.S. Commercially Insured and Medicaid Populations: An Updated Analysis
por: Black, Christopher M., et al.
Publicado: (2021)

Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018
por: Fang, Hanming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q0p3iuc5ptqusmdajaifd30sp4